No Picture
Trading Ideas

Chevron Surprises With Profit Despite Grim Outlook

(Bloomberg) — Chevron Corp. posted a surprise profit as the oil supermajor slashed capital spending to cope with the pandemic-driven collapse in crude demand.The California oil titan posted adjusted per-share earnings of 11 cents for the third quarter, outperforming the average 27-cent loss expected by analysts in a Bloomberg survey. Production from the company’s crude and natural gas wells tumbled to the lowest in more than two years, partly because of intentional decisions to curtail operations that couldn’t turn profits as prices cratered.Things are bad for the industry, Chief Executive Officer Mike Wirth said in a statement, and he provided …read more […]

No Picture
Trading Ideas

Why Schlumberger NV (SLB) Stock is a Compelling Investment Case

First Eagle Investment Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. The First Eagle Global Fund A Shares posted a return of 5.64% for the third quarter (without sales charge), underperforming its benchmark, the MSCI World Index which returned 7.93% in the same quarter. You should check […] …read more […]

No Picture
Trading Ideas

Why Exxon Mobil Corp (XOM) Stock is a Compelling Investment Case

First Eagle Investment Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. The First Eagle Global Fund A Shares posted a return of 5.64% for the third quarter (without sales charge), underperforming its benchmark, the MSCI World Index which returned 7.93% in the same quarter. You should check […] …read more […]

No Picture
Trading Ideas

Biogen Alzheimer’s Drug Faces FDA Panel With Billions at Stake

(Bloomberg) — Biogen Inc.’s big bet that U.S. regulators will approve its experimental drug for Alzheimer’s disease faces a key test next week when a panel of outside advisers reviews results from a pair of studies.The Nov. 6 advisory committee meeting is a highlight of the year for health-care investors and a “major binary event” for the $38 billion drug giant, Stifel analyst Paul Matteis said. Briefing documents, which become public two days before the meeting, are likely to be a “bigger determinant than usual in dictating how panelists eventually vote,” he said.Wall Street analysts have suggested Biogen shares could …read more […]

No Picture
Trading Ideas

Qualcomm, FedEx, auto executives to propose modernized transport policies

A group of business leaders and public policy experts will launch a new body to grapple with thorny questions surrounding the future of transportation including self-driving and electric vehicles. The group, the Future of Mobility Commission, to be formally unveiled Friday, plans to propose a new regulatory framework to address a global transportation sector “on the cusp of a worldwide transition driven by shared, connected, autonomous, and electric technologies.” Alisyn Malek, the commission’s executive director, told Reuters the goal is to tackle tough problems and improve safety. …read more […]